Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tocagen Inc (TOCA)

Tocagen Inc (TOCA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,892
  • Shares Outstanding, K 23,898
  • Annual Sales, $ 18,040 K
  • Annual Income, $ -48,960 K
  • 60-Month Beta 3.89
  • Price/Sales 0.76
  • Price/Cash Flow N/A
  • Price/Book 0.73
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.20
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/12/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.51
  • Number of Estimates 3
  • High Estimate -0.46
  • Low Estimate -0.55
  • Prior Year -0.96
  • Growth Rate Est. (year over year) +46.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.55 +13.92%
on 11/20/19
0.79 -20.25%
on 10/28/19
+0.04 (+6.73%)
since 10/18/19
3-Month
0.53 +18.87%
on 10/14/19
4.91 -87.17%
on 08/21/19
-4.11 (-86.71%)
since 08/20/19
52-Week
0.53 +18.87%
on 10/14/19
14.75 -95.73%
on 12/04/18
-11.04 (-94.60%)
since 11/20/18

Most Recent Stories

More News
Tocagen Reports Third Quarter 2019 Financial Results and Business Updates

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results and business highlights for the third quarter ended September 30, 2019.

TOCA : 0.63 (+8.38%)
Tocagen Highlights Toca 6 Phase 1b Data at Society for Immunotherapy of Cancer Annual Meeting

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced that the Company presented data from the Toca 6 Phase 1b study of Toca 511 and Toca FC in patients...

TOCA : 0.63 (+8.38%)
Tocagen to Report Third Quarter 2019 Financial Results and Business Updates on Tuesday, November 12

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced it will report its third quarter 2019 financial results and business progress on Tuesday, November...

TOCA : 0.63 (+8.38%)
Tocagen Announces Restructuring to Focus on Clinical Development

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced a restructuring to focus its resources on the clinical development of Toca 511 and Toca FC.

TOCA : 0.63 (+8.38%)
Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced that the Toca 5 Phase 3, randomized, multi-center clinical trial evaluating Toca 511 & Toca FC in patients...

TOCA : 0.63 (+8.38%)
Implied Volatility Surging for Tocagen (TOCA) Stock Options

Investors need to pay close attention to Tocagen (TOCA) stock based on the movements in the options market lately.

TOCA : 0.63 (+8.38%)
Tocagen to Participate in Two Upcoming Investor Conferences

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced Marty Duvall, chief executive officer, will present and webcast at the Baird 2019 Global Healthcare...

TOCA : 0.63 (+8.38%)
Tocagen Reports Second Quarter 2019 Financial Results and Business Updates

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results and business highlights for the second quarter ended June 30, 2019.

TOCA : 0.63 (+8.38%)
Tocagen to Report Second Quarter 2019 Financial Results and Business Updates on Thursday, August 8

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced it will report its second quarter 2019 financial results and business progress on Thursday, August...

TOCA : 0.63 (+8.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade TOCA with:

Business Summary

Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company which focuses on retroviral gene therapy platforms. The company's lead product candidate consists of Toca 511 & Toca FC, initially for the treatment of recurrent high grade glioma, a disease with a significant unmet medical need....

See More

Key Turning Points

2nd Resistance Point 0.73
1st Resistance Point 0.68
Last Price 0.63
1st Support Level 0.57
2nd Support Level 0.51

See More

52-Week High 14.75
Fibonacci 61.8% 9.32
Fibonacci 50% 7.64
Fibonacci 38.2% 5.96
Last Price 0.63
52-Week Low 0.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar